Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007–2018 national health insurance claims data

Abstract The aim of this study is to investigate the nationwide incidence and treatment pattern of retinopathy of prematurity (ROP) in South Korea. Using the population-based National Health Insurance database (2007–2018), the nationwide incidence of ROP among premature infants with a gestational ag...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eun Hee Hong, Yong Un Shin, Gi Hwan Bae, Young Jin Choi, Seong Joon Ahn, Lucia Sobrin, Rimkyung Hong, Inah Kim, Heeyoon Cho
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6f561dc187d243d898e147ec84b3dd96
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6f561dc187d243d898e147ec84b3dd96
record_format dspace
spelling oai:doaj.org-article:6f561dc187d243d898e147ec84b3dd962021-12-02T14:01:20ZNationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007–2018 national health insurance claims data10.1038/s41598-021-80989-z2045-2322https://doaj.org/article/6f561dc187d243d898e147ec84b3dd962021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-80989-zhttps://doaj.org/toc/2045-2322Abstract The aim of this study is to investigate the nationwide incidence and treatment pattern of retinopathy of prematurity (ROP) in South Korea. Using the population-based National Health Insurance database (2007–2018), the nationwide incidence of ROP among premature infants with a gestational age (GA) < 37 weeks (GA < 28 weeks, GA28; 28 weeks ≤ GA < 37 weeks; GA28-37) and the percentage of ROP infants who underwent treatment [surgery (vitrectomy, encircling/buckling); retinal ablation (laser photocoagulation, cryotherapy)] were evaluated. We identified 141,964 premature infants, 42,300 of whom had ROP, with a nationwide incidence of 29.8%. The incidence of ROP in GA28 group was 4.3 times higher than in GA28-37 group (63.6% [2240/3522] vs 28.9% [40,060/138,442], p < 0.001). As for the 12-year trends, the incidence of ROP decreased from 39.5% (3308/8366) in 2007 to 23.5% (2943/12,539) in 2018. 3.0% of ROP infants underwent treatment (25.0% in GA28; 1.7% in GA28-37); 0.2% (84/42,300) and 2.9% (1214/42,300) underwent surgery and retinal ablation, respectively. The overall percentage of ROP infants who underwent treatment has decreased from 4.7% in 2007 to 1.8% in 2018. This first Korean nationwide epidemiological study of ROP revealed a decreased incidence of ROP and a decreased percentage of ROP infants undergoing conventional treatment during a 12-year period.Eun Hee HongYong Un ShinGi Hwan BaeYoung Jin ChoiSeong Joon AhnLucia SobrinRimkyung HongInah KimHeeyoon ChoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Eun Hee Hong
Yong Un Shin
Gi Hwan Bae
Young Jin Choi
Seong Joon Ahn
Lucia Sobrin
Rimkyung Hong
Inah Kim
Heeyoon Cho
Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007–2018 national health insurance claims data
description Abstract The aim of this study is to investigate the nationwide incidence and treatment pattern of retinopathy of prematurity (ROP) in South Korea. Using the population-based National Health Insurance database (2007–2018), the nationwide incidence of ROP among premature infants with a gestational age (GA) < 37 weeks (GA < 28 weeks, GA28; 28 weeks ≤ GA < 37 weeks; GA28-37) and the percentage of ROP infants who underwent treatment [surgery (vitrectomy, encircling/buckling); retinal ablation (laser photocoagulation, cryotherapy)] were evaluated. We identified 141,964 premature infants, 42,300 of whom had ROP, with a nationwide incidence of 29.8%. The incidence of ROP in GA28 group was 4.3 times higher than in GA28-37 group (63.6% [2240/3522] vs 28.9% [40,060/138,442], p < 0.001). As for the 12-year trends, the incidence of ROP decreased from 39.5% (3308/8366) in 2007 to 23.5% (2943/12,539) in 2018. 3.0% of ROP infants underwent treatment (25.0% in GA28; 1.7% in GA28-37); 0.2% (84/42,300) and 2.9% (1214/42,300) underwent surgery and retinal ablation, respectively. The overall percentage of ROP infants who underwent treatment has decreased from 4.7% in 2007 to 1.8% in 2018. This first Korean nationwide epidemiological study of ROP revealed a decreased incidence of ROP and a decreased percentage of ROP infants undergoing conventional treatment during a 12-year period.
format article
author Eun Hee Hong
Yong Un Shin
Gi Hwan Bae
Young Jin Choi
Seong Joon Ahn
Lucia Sobrin
Rimkyung Hong
Inah Kim
Heeyoon Cho
author_facet Eun Hee Hong
Yong Un Shin
Gi Hwan Bae
Young Jin Choi
Seong Joon Ahn
Lucia Sobrin
Rimkyung Hong
Inah Kim
Heeyoon Cho
author_sort Eun Hee Hong
title Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007–2018 national health insurance claims data
title_short Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007–2018 national health insurance claims data
title_full Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007–2018 national health insurance claims data
title_fullStr Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007–2018 national health insurance claims data
title_full_unstemmed Nationwide incidence and treatment pattern of retinopathy of prematurity in South Korea using the 2007–2018 national health insurance claims data
title_sort nationwide incidence and treatment pattern of retinopathy of prematurity in south korea using the 2007–2018 national health insurance claims data
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6f561dc187d243d898e147ec84b3dd96
work_keys_str_mv AT eunheehong nationwideincidenceandtreatmentpatternofretinopathyofprematurityinsouthkoreausingthe20072018nationalhealthinsuranceclaimsdata
AT yongunshin nationwideincidenceandtreatmentpatternofretinopathyofprematurityinsouthkoreausingthe20072018nationalhealthinsuranceclaimsdata
AT gihwanbae nationwideincidenceandtreatmentpatternofretinopathyofprematurityinsouthkoreausingthe20072018nationalhealthinsuranceclaimsdata
AT youngjinchoi nationwideincidenceandtreatmentpatternofretinopathyofprematurityinsouthkoreausingthe20072018nationalhealthinsuranceclaimsdata
AT seongjoonahn nationwideincidenceandtreatmentpatternofretinopathyofprematurityinsouthkoreausingthe20072018nationalhealthinsuranceclaimsdata
AT luciasobrin nationwideincidenceandtreatmentpatternofretinopathyofprematurityinsouthkoreausingthe20072018nationalhealthinsuranceclaimsdata
AT rimkyunghong nationwideincidenceandtreatmentpatternofretinopathyofprematurityinsouthkoreausingthe20072018nationalhealthinsuranceclaimsdata
AT inahkim nationwideincidenceandtreatmentpatternofretinopathyofprematurityinsouthkoreausingthe20072018nationalhealthinsuranceclaimsdata
AT heeyooncho nationwideincidenceandtreatmentpatternofretinopathyofprematurityinsouthkoreausingthe20072018nationalhealthinsuranceclaimsdata
_version_ 1718392205622640640